Analyses of immune status in cancer patients

Analyses of immune status in malignant tumor patients - Immune status in malignant tumor patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040469

Enrollment

150

Registered

2020-05-21

Start date

2020-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed or clinically suspected malignant tumor patients. 2) Patients have plans to receive any therapies. 3) Written informed consents are obtained.

Exclusion criteria

Exclusion criteria: 1) Clinicians judge as ineligible cases.

Design outcomes

Primary

Measure	Time frame
Correlation between immune profiling and clinicopathological features	—

Countries

Japan

Contacts

Public ContactYosuke Togashi

Chiba Cancer Center Research Institute

ytogashi@chiba-cc.jp0432645431

Outcome results